Skip to main content

Alecnib 150 mg ( Alectinib)

Alecnib 150 mg is identified on this website as a product containing alectinib, an oral targeted anticancer medicine used for certain patients with ALK-positive non-small cell lung cancer (NSCLC).

Product verification is an important step before using any prescription anticancer medicine. Patients, caregivers, pharmacists, and healthcare professionals should confirm the medicine’s identity, stated strength, manufacturer information, packaging details, batch number, expiry date, and regulatory status.

A product name or a stated strength alone does not establish that a medicine is genuine, properly manufactured, or authorized for sale.

This page explains general steps for checking the identity and documentation of an alectinib product. It does not certify the authenticity or regulatory approval of Alecnib.

1. What Is Product Verification?

Product verification is the process of checking whether a medicine’s identity and supporting documentation are consistent with reliable manufacturer and regulatory information.

For prescription medicines such as alectinib, verification helps patients and healthcare professionals identify discrepancies that may indicate an incorrectly labeled, falsified, damaged, or unauthorized product.

Verification may involve checking:

  • Product name.
  • Active ingredient.
  • Stated strength.
  • Dosage form.
  • Manufacturer’s legal name.
  • Manufacturing information.
  • Batch or lot number.
  • Expiry date.
  • Packaging integrity.
  • Product registration or authorization details.
  • Applicable prescribing and patient information.

These checks are important because the appearance of a package alone cannot prove the identity or quality of the medicine inside.

2. What Is Alecnib 150 mg?

Alecnib is identified on this website as a product containing alectinib with a stated strength of 150 mg.

Alectinib is a selective ALK tyrosine kinase inhibitor used in the treatment of certain patients with ALK-positive NSCLC.

The following product-specific details require confirmation through original packaging and reliable documentation:

Product informationVerification status
Website-listed nameAlecnib
Stated strength150 mg
Active ingredient identified on this websiteAlectinib
ManufacturerNot independently verified
Manufacturing locationNot independently verified
Exact dosage formRequires packaging confirmation
Regulatory authorizationNot independently verified
Batch-specific authenticityRequires independent verification

Patients should not interpret the information on this website as confirmation that a particular package of Alecnib is genuine or authorized.

3. Why Is Alecnib Verification Important?

Alectinib is a prescription anticancer medicine. Patients receiving cancer treatment depend on accurate product identification, appropriate manufacturing standards, and suitable medicine handling.

Using an incorrectly identified or falsified medicine may expose patients to serious risks.

Product verification is important because it can help identify:

  • Incorrect active ingredients.
  • Incorrect stated strengths.
  • Misleading manufacturer information.
  • Altered or incomplete packaging.
  • Expired medicines.
  • Unverified manufacturing sources.
  • Products without appropriate authorization.
  • Possible storage or handling problems.

Verification is particularly important for prescription cancer medicines because treatment decisions and dosage depend on the actual medicine being supplied.

4. Check the Active Ingredient

The first step is to confirm the active ingredient stated on the product packaging.

Alecnib is identified on this website as containing alectinib. Patients should check that the original packaging and accompanying product documentation clearly identify the active ingredient.

Do not assume that a medicine contains alectinib simply because its name resembles another alectinib brand.

The active ingredient should be confirmed through reliable product documentation and, where necessary, a licensed pharmacist or relevant regulatory authority.

5. Verify the Stated Strength

The website identifies Alecnib as a 150 mg product.

Before using the medicine, compare the strength printed on the original packaging with the prescribed product and dispensing documentation.

Check that:

  • The strength is clearly stated.
  • The product information identifies the active ingredient.
  • The packaging is consistent with the prescription.
  • The supplied dosage form is appropriate.
  • The dispensing instructions match the healthcare professional’s directions.

A stated strength does not establish that the product has the correct amount of active ingredient or meets pharmaceutical quality standards. Those matters require appropriate quality and regulatory verification.

6. Check the Dosage Form

Alectinib reference products may be supplied in specific oral dosage forms. However, the exact formulation of Alecnib should be confirmed from its original packaging and manufacturer documentation.

Patients should not assume that every product containing alectinib is supplied in an identical form.

Check the packaging for:

  • Dosage form identification.
  • Strength per unit.
  • Route of administration.
  • Administration instructions.
  • Patient information.
  • Storage requirements.

If the dosage form is unclear or differs from the prescription, consult a pharmacist before using the medicine.

7. Verify the Manufacturer

Manufacturer verification is an important part of medicine identification.

Patients and healthcare professionals should look for the manufacturer’s full legal name and relevant manufacturing information on the packaging or official product documentation.

Where available, verify:

  • Full manufacturer name.
  • Manufacturing address.
  • Manufacturing site information.
  • Applicable manufacturing authorization.
  • Product registration details.
  • Batch documentation.
  • Manufacturer-issued product information.

The manufacturer of Alecnib has not been independently established by the information presented on this website.

Do not assume that Alecnib is manufactured by the company associated with another established alectinib brand. Similar active ingredients do not establish a shared manufacturer or commercial relationship.

8. Check the Batch or Lot Number

A batch or lot number helps identify a specific manufacturing batch of a medicine.

Patients should check that the batch information is present and readable on the packaging.

Important checks include:

  • Whether a batch number is printed.
  • Whether the number is legible.
  • Whether packaging components show consistent batch information where applicable.
  • Whether the batch details can be confirmed through the manufacturer or authorized supplier.

A batch number by itself does not prove authenticity. It should be checked against reliable manufacturing or supply documentation when verification is necessary.

If a batch number is missing, altered, or appears inconsistent, do not use the medicine until the concern has been assessed by a pharmacist or relevant authority.

9. Check the Expiry Date

The expiry date indicates the period during which the manufacturer supports the medicine’s quality under specified storage conditions.

Before using Alecnib, check the expiry date printed on the original packaging.

Patients should:

  • Confirm that the medicine has not expired.
  • Check that the expiry information is readable.
  • Avoid products with altered or unclear expiry markings.
  • Avoid using damaged or improperly stored medicines.
  • Ask a pharmacist about products with questionable expiry information.

An unexpired medicine is not automatically genuine. Expiry checks should be combined with other verification steps.

10. Inspect the Original Packaging

Packaging inspection can help identify visible inconsistencies that require further investigation.

Before accepting a medicine, check:

  1. The product name is clearly printed.
  2. The active ingredient is identified.
  3. The stated strength is visible.
  4. The dosage form is specified.
  5. The manufacturer information is available.
  6. The batch number is present.
  7. The expiry date is readable.
  8. The packaging is intact.
  9. Required labeling and patient information are included.
  10. There are no obvious signs of tampering or alteration.

Be cautious if packaging contains spelling errors, inconsistent printing, missing information, or unexplained differences between components.

However, professional-looking packaging is not proof of authenticity. Some falsified medicines can imitate genuine packaging.

11. Verify Regulatory Authorization

Medicine authorization is handled by national or regional regulatory authorities.

The regulatory status of a medicine may vary between countries. A product authorized in one jurisdiction is not automatically authorized in another.

To investigate alectinib product authorization, patients or healthcare professionals should:

  • Identify the country where the medicine is being supplied.
  • Obtain the manufacturer’s legal name.
  • Obtain the exact product name and strength.
  • Request the product registration or authorization number.
  • Check the relevant national medicines regulator’s records.
  • Confirm that the authorization applies to the specific product and manufacturer.

For medicines supplied in Bangladesh, relevant product authorization information should be checked through the Directorate General of Drug Administration (DGDA), where applicable.

The regulatory status of Alecnib has not been independently confirmed on this website.

12. How to Identify Potentially Falsified Medicines

Falsified medicines may contain incorrect ingredients, incorrect strengths, inadequate amounts of active ingredients, or potentially harmful substances.

Warning signs may include:

  • Missing manufacturer details.
  • Missing or altered batch information.
  • Unreadable expiry dates.
  • Broken or suspicious packaging seals.
  • Incorrect product labeling.
  • Unexplained differences between supplied and expected packaging.
  • Unusually inconsistent product information.
  • A supplier unable to provide reliable documentation.
  • Offers that bypass normal prescription requirements.

These warning signs do not independently prove that a product is falsified. They indicate that the medicine requires further investigation.

If falsification is suspected, do not use the product. Contact the dispensing pharmacist and appropriate regulatory authority.

13. Verify the Medicine Through an Authorized Pharmacy

A licensed or appropriately authorized pharmacy can help patients assess prescription medicine documentation and identify inconsistencies.

When obtaining Alecnib, patients should consider whether the pharmacy:

  • Requires an appropriate prescription.
  • Provides clear dispensing documentation.
  • Can identify the medicine’s manufacturer.
  • Can explain the product’s stated strength and dosage form.
  • Can provide batch and expiry information.
  • Obtains medicines through legitimate supply channels.
  • Can refer product verification questions to the relevant manufacturer or regulator.

Avoid purchasing prescription anticancer medicines from suppliers who cannot provide reliable product information.

14. What Documents Can Support Product Verification?

Depending on the country and the product, different documents may support verification.

Examples include:

DocumentPurpose
Original product packagingIdentifies the product and stated details
Manufacturer documentationSupports manufacturer and product identification
Product registration informationHelps establish regulatory authorization
Batch informationIdentifies a particular manufacturing batch
Certificate of AnalysisProvides batch-related quality test information when properly issued and verified
Product information leafletExplains approved or documented administration and safety information
Pharmacy dispensing recordDocuments the supply of the medicine

The availability and relevance of these documents vary. A document should be checked for its issuing organization, authenticity, product identity, and applicability to the supplied batch.

A Certificate of Analysis, for example, should not be treated as proof of authenticity merely because a supplier provides a document with that title.

15. What Should You Do If Product Information Does Not Match?

If the product name, strength, dosage form, manufacturer, batch number, or other details do not match the prescription or expected documentation, do not use the medicine until the discrepancy is resolved.

Recommended steps include:

  1. Keep the medicine and its packaging.
  2. Do not alter or discard the original labeling.
  3. Contact the dispensing pharmacy.
  4. Request clarification from the supplier.
  5. Ask for relevant manufacturer documentation.
  6. Consult the prescribing oncologist if the product identity remains uncertain.
  7. Contact the relevant regulatory authority when necessary.

Patients should not attempt to verify a medicine by taste, appearance, or other unsafe methods.

16. Is Alecnib the Same as Alecensa?

Alecnib and Alecensa are different product names associated with alectinib information.

Alecensa is an established reference brand of alectinib. However, the presence of the same active ingredient or stated strength does not establish that Alecnib is manufactured by the same company, has the same formulation, or holds the same regulatory authorization.

The following details should be independently confirmed before assuming that two products are equivalent:

  • Active ingredient and strength.
  • Dosage form.
  • Manufacturer.
  • Manufacturing standards.
  • Product registration.
  • Applicable prescribing information.
  • Pharmaceutical quality and interchangeability.

A healthcare professional or pharmacist should confirm whether a specific product can be used as an alternative to another prescribed product.

17. Information for Healthcare Professionals

Healthcare professionals involved in prescribing or dispensing alectinib should verify the product identity and relevant documentation before use.

Professional assessment may include:

  • Confirming the active ingredient and strength.
  • Reviewing the manufacturer’s identity.
  • Checking applicable registration information.
  • Assessing packaging and batch documentation.
  • Reviewing the product’s prescribing information.
  • Confirming the dosage form.
  • Checking storage and handling requirements.
  • Reviewing potential product substitution concerns.

Where product identity or authorization cannot be established, the medicine should not be treated as verified.

18. Product Verification Checklist

The following checklist can help patients and caregivers organize basic verification steps.

Verification progress

0/11 checkedConfirm the product name and active ingredient.Check the stated 150 mg strength against the prescription.Confirm the dosage form.Identify the manufacturer’s full legal name.Check the batch or lot number.Check the expiry date.Inspect packaging for damage or tampering.Review the product information leaflet.Request appropriate manufacturer documentation.Check applicable regulatory authorization.Ask a licensed pharmacist to review any discrepancy.

Reset checklist

This checklist helps organize verification. Completing it does not independently certify product authenticity or pharmaceutical quality.

19. Important Questions About Alecnib Verification

Has Alecnib been independently verified?

The manufacturer, batch-specific authenticity, and regulatory authorization of Alecnib have not been independently established by the information presented on this website.

Is Alecnib approved by the FDA?

This website does not establish FDA authorization for Alecnib. Any claim of approval should be checked against the relevant official regulatory records.

Is Alecnib manufactured by Roche?

The manufacturer of Alecnib has not been independently confirmed. Roche and Genentech are associated with the reference alectinib brand Alecensa, but that does not establish who manufactures Alecnib.

Does the 150 mg strength prove that the product is genuine?

No. A stated strength is only one product detail. Authenticity requires appropriate verification of the manufacturer, batch, packaging, supply chain, and regulatory documentation.

Can a pharmacist verify Alecnib?

A pharmacist can review the packaging and available documentation and may help contact the supplier or relevant manufacturer. Formal authenticity confirmation may require the manufacturer or regulatory authority.

Should I use Alecnib if the packaging looks different?

Do not assume that a different-looking package is genuine or falsified. Ask a pharmacist to investigate the difference before using the medicine.

Can I use a different alectinib brand if Alecnib is unavailable?

Do not substitute products independently. A qualified healthcare professional or pharmacist must confirm whether an alternative product is appropriate.

What should I do if I suspect a falsified product?

Do not use it. Preserve the packaging and contact the dispensing pharmacy, prescribing healthcare professional, and relevant medicines regulatory authority.

Important Product Verification Disclaimer

The information on this page provides general guidance on checking prescription medicine identity and documentation.

Alecnib is identified on this website as a product containing alectinib in a stated strength of 150 mg. This page does not certify the product’s authenticity, manufacturer, manufacturing location, pharmaceutical quality, batch status, or regulatory authorization.

Product verification must be based on reliable manufacturer documentation, appropriate batch information, and applicable regulatory records. Patients should consult a licensed pharmacist or relevant medicines authority whenever product identity or authenticity is uncertain.